|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
FY2020
12 months to Dec 31, 2020
|
FY2019
12 months to Dec 31, 2019
|
|
|---|---|---|---|---|---|
| Cash Flows from Operating Activities | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash provided by (used in) operating activities | |||||
| Depreciation and amortization | |||||
| Loss on disposal of property and equipment | |||||
| Stock-based compensation | |||||
| Acquired in-process research & development | |||||
| Amortization of debt issuance costs | |||||
| (Reversal of) provision for allowance of credit losses | |||||
| Change in fair value of contingent consideration | |||||
| Deferred income taxes and other items, net | |||||
| Deferred income taxes | |||||
| Other items, net | |||||
| Total deferred income taxes and other items, net | |||||
| Changes in operating assets and liabilities, net of business acquisition | |||||
| Accounts receivable | |||||
| Inventory | |||||
| Prepaid expenses and other current assets | |||||
| Other assets | |||||
| Accounts payable | |||||
| Accrued liabilities | |||||
| Accrued compensation and benefits | |||||
| Operating lease liabilities | |||||
| Payment of contingent consideration | |||||
| Net cash (used in) provided by operating activities | |||||
| Cash Flows from Investing Activities | |||||
| Purchases of property and equipment | |||||
| Acquisition of a business, net of cash acquired | |||||
| Purchases of short-term investments | |||||
| Proceeds from sales and maturities of short-term investments | |||||
| Net cash used in investing activities | |||||
| Cash Flows from Financing Activities | |||||
| Proceeds from exercise of stock options | |||||
| Payment of contingent consideration | |||||
| Payment of debt issuance costs | |||||
| Proceeds from debt | |||||
| Repayment of debt | |||||
| Proceeds from offering of common stock upon follow-on public offering | |||||
| Follow-on Offering | |||||
| Total proceeds from offering of common stock upon follow-on public offering | |||||
| Payment of common stock offering costs upon follow-on public offering | |||||
| Common Stock | |||||
| Total payment of common stock offering costs upon follow-on public offering | |||||
| Net cash (used in) provided by financing activities | |||||
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | |||||
| Net (decrease) increase in cash, cash equivalents and restricted cash | |||||
| Cash and cash equivalents, beginning of year | |||||
| Cash, cash equivalents and restricted cash, end of year | |||||
| Supplemental Disclosure of Cash Flow Information | |||||
| Cash paid for interest | |||||
| Cash paid for taxes | |||||
| Noncash Investing and Financing Activities | |||||
| Property and equipment acquired but not yet paid | |||||
| Property and equipment acquired from tenant improvement allowance | |||||
| Common stock issuance for acquired in-process research & development | |||||
| Common stock issuance for business acquisition | |||||
| Contingent consideration for business acquisition | |||||
| Common stock issuance for exclusive license asset | |||||
| Accrued loan fees as debt issuance costs | |||||
Loading...